000276083 001__ 276083
000276083 005__ 20240229154956.0
000276083 0247_ $$2doi$$a10.26508/lsa.202201740
000276083 0247_ $$2pmid$$apmid:37188479
000276083 0247_ $$2pmc$$apmc:PMC10185812
000276083 0247_ $$2altmetric$$aaltmetric:148402936
000276083 037__ $$aDKFZ-2023-00989
000276083 041__ $$aEnglish
000276083 082__ $$a570
000276083 1001_ $$aGregorczyk, Mateusz$$b0
000276083 245__ $$aFunctional characterization of C21ORF2 association with the NEK1 kinase mutated in human in diseases.
000276083 260__ $$aHeidelberg$$bEMBO Press$$c2023
000276083 3367_ $$2DRIVER$$aarticle
000276083 3367_ $$2DataCite$$aOutput Types/Journal article
000276083 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1684486819_25823
000276083 3367_ $$2BibTeX$$aARTICLE
000276083 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000276083 3367_ $$00$$2EndNote$$aJournal Article
000276083 500__ $$aDKFZ-ZMBH Alliance
000276083 520__ $$aThe NEK1 kinase controls ciliogenesis, mitosis, and DNA repair, and NEK1 mutations cause human diseases including axial spondylometaphyseal dysplasia and amyotrophic lateral sclerosis. C21ORF2 mutations cause a similar pattern of human diseases, suggesting close functional links with NEK1 Here, we report that endogenous NEK1 and C21ORF2 form a tight complex in human cells. A C21ORF2 interaction domain 'CID' at the C-terminus of NEK1 is necessary for its association with C21ORF2 in cells, and pathogenic mutations in this region disrupt the complex. AlphaFold modelling predicts an extended binding interface between a leucine-rich repeat domain in C21ORF2 and the NEK1-CID, and our model may explain why pathogenic mutations perturb the complex. We show that NEK1 mutations that inhibit kinase activity or weaken its association with C21ORF2 severely compromise ciliogenesis, and that C21ORF2, like NEK1 is required for homologous recombination. These data enhance our understanding of how the NEK1 kinase is regulated, and they shed light on NEK1-C21ORF2-associated diseases.
000276083 536__ $$0G:(DE-HGF)POF4-311$$a311 - Zellbiologie und Tumorbiologie (POF4-311)$$cPOF4-311$$fPOF IV$$x0
000276083 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000276083 650_7 $$0EC 2.7.11.1$$2NLM Chemicals$$aNIMA-Related Kinase 1
000276083 650_7 $$0EC 2.7.11.1$$2NLM Chemicals$$aNEK1 protein, human
000276083 650_2 $$2MeSH$$aHumans
000276083 650_2 $$2MeSH$$aNIMA-Related Kinase 1: genetics
000276083 650_2 $$2MeSH$$aMutation: genetics
000276083 650_2 $$2MeSH$$aDNA Repair
000276083 650_2 $$2MeSH$$aOsteochondrodysplasias: genetics
000276083 650_2 $$2MeSH$$aPhosphorylation
000276083 7001_ $$00000-0002-5668-8452$$aPastore, Graziana$$b1
000276083 7001_ $$aMuñoz, Ivan$$b2
000276083 7001_ $$aCarroll, Thomas$$b3
000276083 7001_ $$0P:(DE-He78)9a08f3e289ddc5ed640e790e98e2f9ef$$aStreubel, Johanna$$b4$$udkfz
000276083 7001_ $$aMunro, Meagan$$b5
000276083 7001_ $$00000-0002-4978-7671$$aLis, Pawel$$b6
000276083 7001_ $$00000-0002-6011-8647$$aLange, Sven$$b7
000276083 7001_ $$aLamoliatte, Frederic$$b8
000276083 7001_ $$00000-0002-6745-183X$$aMacartney, Thomas$$b9
000276083 7001_ $$00000-0002-1337-0612$$aToth, Rachel$$b10
000276083 7001_ $$aBrown, Fiona$$b11
000276083 7001_ $$00000-0001-7164-4098$$aHastie, James$$b12
000276083 7001_ $$0P:(DE-He78)5138c10dcd0901d001d67a31423402b5$$aPereira, Gislene$$b13$$udkfz
000276083 7001_ $$00000-0003-3863-8635$$aDurocher, Daniel$$b14
000276083 7001_ $$00000-0003-1183-8303$$aRouse, John$$b15
000276083 773__ $$0PERI:(DE-600)2948687-7$$a10.26508/lsa.202201740$$gVol. 6, no. 7, p. e202201740 -$$n7$$pe202201740 -$$tLife science alliance$$v6$$x2575-1077$$y2023
000276083 909CO $$ooai:inrepo02.dkfz.de:276083$$pVDB
000276083 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)9a08f3e289ddc5ed640e790e98e2f9ef$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000276083 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)5138c10dcd0901d001d67a31423402b5$$aDeutsches Krebsforschungszentrum$$b13$$kDKFZ
000276083 9131_ $$0G:(DE-HGF)POF4-311$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vZellbiologie und Tumorbiologie$$x0
000276083 9141_ $$y2023
000276083 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2022-02-08T19:01:09Z
000276083 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2022-02-08T19:01:09Z
000276083 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2022-02-08T19:01:09Z
000276083 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2023-03-31
000276083 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-03-31
000276083 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-03-31
000276083 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2023-03-31
000276083 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2023-03-31
000276083 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bLIFE SCI ALLIANCE : 2022$$d2023-10-27
000276083 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-27
000276083 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-27
000276083 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-10-27
000276083 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2022-02-08T19:01:09Z
000276083 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-27
000276083 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-27
000276083 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-27
000276083 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-10-27
000276083 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-10-27
000276083 9201_ $$0I:(DE-He78)A180-20160331$$kA180$$lA180 Molecular Biology of Centrosomes$$x0
000276083 980__ $$ajournal
000276083 980__ $$aVDB
000276083 980__ $$aI:(DE-He78)A180-20160331
000276083 980__ $$aUNRESTRICTED